Inflammation in Tinnitus

Inflammation Clinical Trial

— INFLATIN  

Official title:

The Role of Inflammation in the Pathogenesis of Tinnitus

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05268770
• Other study ID #: 202200148
• Status: Not yet recruiting
• Start date: March 2022
• Est. completion date: August 2022

Study information

• Verified date: February 2022
• Source: University Medical Center Groningen
• Contact: Lilian M Mennink, MD
• Phone: 0031503610522
• Email: l.m.mennink[@]umcg.nl
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Rationale: Tinnitus is the perception of sound without an external source. In the past decade, inflammation has been implicated in the pathophysiology of tinnitus. In animal models of tinnitus, the expression of proinflammatory cytokines Tumor Necrosis Factor-α (TNF-α) and interleukine-1β (IL-1β) was increased throughout the whole auditory tract. Only two studies evaluated cytokine concentrations in tinnitus patients. In these studies an increase of IL-6 and decrease of IL-10 have been objectified. However, studies did not include tinnitus patients based on the degree of hearing loss, despite that inflammation has also been implicated in hearing loss. On the other hand, studies about inflammation in hearing loss did not (always) exclude tinnitus. Thus, it remains unclear whether the upregulated cytokine concentrations the studies are specific for tinnitus, and whether potential effects remained unsignificant because the presence of hearing loss is a confounder. Therefore, the aim of this study is to evaluate the presence of inflammation in tinnitus patients with normal hearing.

Objective: The main objective is to evaluate the presence of inflammation in blood samples of human subjects with tinnitus and normal hearing, compared to healthy controls. The secondary objective is to evaluate the relation between tinnitus severity and inflammatory marker concentrations.

Study design: This is a cross-sectional study.

Study population: Patients who have been referred to the tinnitus consultation at the outpatient clinic will be asked to participate in this study. For the control group, healthy volunteers will be recruited.

Main study parameters/endpoints: The main study parameter is the disparity in blood cytokine levels between participants with and without tinnitus. Secondary study parameters are the relation between tinnitus severity and blood cytokine concentration, and the difference in complete blood count measures in participants with and without tinnitus.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: August 2022
• Est. primary completion date: August 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• To be eligible to participate in this study, a subject must meet all of the following criteria:

• Adult, aged 18 years or older;

• Hearing threshold: average of 1000kHz, 2000kHz & 4000kHz = 25 dB.

• Anxiety score HADS = 7

• Depression score HADS = 7

• Participant has sufficient mastery of the Dutch language to fill out the questionnaires.

• Psychosocially, mentally, and physically able to fully comply with this protocol.

Exclusion Criteria:

• Objective tinnitus.

• Presence of neurological disease (apart from tinnitus)

• Presence of inflammatory disease, or the use of anti-inflammatory medication.

• Presence or history of a malignancy

• Presence of a disease of the ear (e.g. chronic otitis media, otosclerosis, previous surgery etc).

• Presence of an coagulation disorder

• Presence of a serious psychiatric disorder.

• Pregnancy

Related Conditions & MeSH terms

• Inflammation
• Tinnitus
• Tinnitus, Subjective

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University Medical Center Groningen

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Tinnitus vs no tinnitus	Difference in cytokine levels between participants with and without tinnitus	September 2022
Secondary	Tinnitus severity	Relation between cytokine levels and tinnitus severity	September 2022